Original language | English (US) |
---|---|
Pages (from-to) | e87-e91 |
Journal | JACC: Cardiovascular Interventions |
Volume | 14 |
Issue number | 9 |
DOIs | |
State | Published - May 10 2021 |
Bibliographical note
Funding Information:The funding and CoreValve Evolut TAVR products for this work were provided through a research contract with Medtronic. Dr. Sanchez is employed by Medtronic. Dr. Burzotta received speaker fees from Abbott, Medtronic, and Abiomed. Dr. Iaizzo has a research contract with Medtronic and serves as an educational consultant. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Keywords
- PCI
- TAVR
- coronary artery management
- personalized medicine